Abstract: The present invention provides a composition for treating or preventing renal cell cancer, the composition comprising, as an active ingredient, D-allose and/or a derivative thereof and/or a mixture thereof, and being characterized by being administered through the intestinal tract (for example, oral administration). Moreover, the present invention provides a method for treating or preventing renal cell cancer in a subject, the method comprising administering a composition, which is for treating or preventing renal cell cancer and contains D-allose as an active ingredient, to a subject in need thereof through the intestinal tract (for example, oral administration).

Abstract: Provided is a pharmaceutical composition that is for prevention or treatment of urinary tract organ cancer, causes no adverse side effects, can be continuously used for a long time, and is administered to the urinary tract organ by injection into the urinary tract organ cavity. A solution for injection into the urinary tract organ cavity contains D-allose. The inside of the urinary tract organ cavity is the inside of the upper urinary tract and the inside of the bladder. The solution is for injection therapy into the urinary tract organ cavity. The solution uses enhancement of sugar uptake into cancer cells of the urinary tract organ (for example, RT112, 253J, J82) by D-allose. The solution contains D-allose together with a pharmaceutically acceptable diluent or carrier. The solution is a pharmaceutical composition for prevention or treatment of urinary tract organ cancer.

Abstract: To provide a composition for the treatment of renal cell carcinoma and a composition or a method for enhancing the uptake of a drug into renal cell carcinoma cells. Provided are a D-allose-containing composition for the treatment of renal cell carcinoma, and a D-allose-containing composition or method for enhancing the uptake of a drug into renal cell carcinoma cells. The composition is a pharmaceutical composition to be administered in an effective amount to patients requiring the treatment of renal cell carcinoma in humans or animals other than humans.

Abstract: The present invention is intended to provide a method for producing a liquid metal chelate compound which may be used as it is or diluted in water or the like, in a very simple procedure, in a short time, in a large quantity, and at a low cost, and to provide a metal chelate compound. A metal is ground in a liquid containing an organic acid to form an unoxidized fine metal powder. For example, a metal is ground in a liquid containing the organic acid, or the organic acid is added after the metal is ground in a liquid, or the organic acid is added while grinding the metal in a liquid. The unoxidized fine metal powder is oxidized in the liquid containing an organic acid to generate a metal ion. As a result of this, the unoxidized fine metal powder is chemically bonded to the organic acid in the liquid thereby producing a liquid metal chelate compound. The liquid metal chelate compound is adsorbed by an absorber.

Abstract: A system for laying a subterranean water impervious asphalt layer which is mounted on a tractor and includes a liquidized asphalt supply tank and a subterranean plough provided with a plurality of outlet ports so that liquidized asphalt is fed from the tank through a liquidized ashalt supply pipe connecting the tank to the ports by a liquidized asphalt supply pump provided in the pipe and driven by a hydraulic motor so that liquidized asphalt is discharged by the ports to form a water impervious asphalt layer into a subterranean cavity. The system is provided with a hydraulic pump driven by an engine of the tractor and connected to the hydraulic motor and a switching valve provided in the lines connecting the hydraulic pump to the hydraulic motor so that the hydraulic motor is driven in the forward or reverse direction as well as is held standstill by the actuation of the switching valve.